Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oramed Pharmaceuticals (ORMP) Current Assets (2016 - 2026)

Oramed Pharmaceuticals filings provide 15 years of Current Assets readings, the most recent being $133.3 million for Q4 2025.

  • Quarterly Current Assets fell 6.95% to $133.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $133.3 million through Dec 2025, down 6.95% year-over-year, with the annual reading at $133.3 million for FY2025, 6.95% down from the prior year.
  • Current Assets hit $133.3 million in Q4 2025 for Oramed Pharmaceuticals, down from $136.1 million in the prior quarter.
  • Across five years, Current Assets topped out at $177.1 million in Q1 2024 and bottomed at $57.5 million in Q1 2021.
  • Average Current Assets over 5 years is $136.7 million, with a median of $143.4 million recorded in 2022.
  • The largest annual shift saw Current Assets surged 322.86% in 2021 before it tumbled 35.39% in 2025.
  • Oramed Pharmaceuticals' Current Assets stood at $152.3 million in 2021, then grew by 3.14% to $157.1 million in 2022, then increased by 3.48% to $162.6 million in 2023, then dropped by 11.91% to $143.2 million in 2024, then decreased by 6.95% to $133.3 million in 2025.
  • Per Business Quant, the three most recent readings for ORMP's Current Assets are $133.3 million (Q4 2025), $136.1 million (Q3 2025), and $99.0 million (Q2 2025).